Financials data is unavailable for this security.
View more
Year on year US Neurosurgical Holdings Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 1.34m to a smaller loss of 816.00k.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -45.80% |
|---|---|
| Return on equity | -75.67% |
| Return on investment | -66.91% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at US Neurosurgical Holdings Inc fell by 1.07m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 891.00k for operations while cash used for investing totalled 180.00k.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.1482 |
|---|---|
| Tangible book value per share | 0.1482 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.30 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 48.45%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -98.23 |
